We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current XOMAP market cap is 290.76M. The company's latest EPS is USD -3.5542 and P/E is -7.17.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.49M | 437k | 1.66M | 830k | 1.83M |
| Operating Income | -6.21M | -10.17M | -4.38M | -5.79M | -19.93M |
| Net Income | -1.87M | -11.18M | -6.77M | -6.88M | -16.01M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 18.37M | 29.39M | 38.16M | 6.03M | 4.76M |
| Operating Income | -3.89M | 12.42M | 17.53M | -17.41M | -40.27M |
| Net Income | -1.98M | 13.3M | 15.8M | -17.1M | -40.83M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 140.38M | 133.66M | 125.66M | 124.09M | 234.3M |
| Total Liabilities | 16.37M | 19.14M | 15.54M | 18.13M | 145.58M |
| Total Equity | 124.01M | 114.53M | 110.12M | 105.96M | 88.72M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 95.72M | 125.29M | 166.56M | 140.38M | 234.3M |
| Total Liabilities | 51.74M | 38.86M | 24.69M | 16.37M | 145.58M |
| Total Equity | 43.99M | 86.42M | 141.88M | 124.01M | 88.72M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -12.88M | -4.92M | -12.13M | -14.23M | -18.16M |
| Investing | -20.22M | -7.23M | -11.72M | -6.22M | -711k |
| Financing | -4.45M | -1.37M | -2.53M | -3.9M | 120.59M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -285k | 10.09M | 22.68M | -12.88M | -18.16M |
| Investing | -19.3M | -209k | -26.5M | -20.22M | -711k |
| Financing | 30.49M | 19.79M | 12.84M | -4.45M | 120.59M |
| Market Cap | 290.76M |
| Price to Earnings Ratio | -7.17 |
| Price to Sales Ratio | 61.56 |
| Price to Cash Ratio | 1.91 |
| Price to Book Ratio | 3.3 |
| Dividend Yield | - |
| Shares Outstanding | 11.49M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 1 (3.86%) |
| Company Name | XOMA Corporation |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.xoma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
